Compatibility of aztreonam in four commercial peritoneal dialysis fluids

Sci Rep. 2020 Feb 4;10(1):1788. doi: 10.1038/s41598-020-58391-y.

Abstract

The preferable route for treatment of peritoneal dialysis related peritonitis remains the intraperitoneal administration of antibiotics admixed to peritoneal dialysis fluids. It is important to know whether the administered drug is compatible with the PD fluids and its container. In the present study the compatibility of aztreonam with four commercial PDFs at storing temperatures and duration representative for storing conditions in the clinical settings was investigated. Aztreonam concentrations were determined using high-performance liquid chromatography. The antimicrobial activity of aztreonam was evaluated using an E. coli diffusion disk inhibition assay and P. aeruginosa time-kill curves. In Extraneal evaluated at 6 °C, 25 °C and 37 °C aztreonam was stable over the whole study period of 14 days and 24 hours, respectively. In Physioneal and Nutrineal aztreonam was stable at 6 °C for up to 14 days. Antimicrobial activity was retained in all PD fluids over the whole study period. Aztreonam remained stable and was compatible with the PD fluids, particularly with Extraneal or Nutrineal, and no compensatory dose adjustment is needed when stored for up to 14 days at refrigeration temperature before use.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / analysis
  • Anti-Bacterial Agents / therapeutic use*
  • Aztreonam / administration & dosage
  • Aztreonam / analysis
  • Aztreonam / therapeutic use*
  • Dialysis Solutions / chemistry*
  • Drug Administration Routes
  • Humans
  • Peritoneal Dialysis / adverse effects*
  • Peritoneal Dialysis / methods
  • Peritonitis / drug therapy*
  • Peritonitis / etiology

Substances

  • Anti-Bacterial Agents
  • Dialysis Solutions
  • Aztreonam